Company research
Apollomics Inc.
CIK 1944885Updated Sep 25, 2026
APLM price & chart
Loading TradingView…
NASDAQ:APLM on TradingView ↗In the news
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia ↗
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | -53,858,000Source | -172,601,000Source | -240,811,000Source | -94,797,000Source |
| Cash flows from financing activities: | ||||
| Dividends paid | — | — | — | — |
| Additional Financial Items | ||||
| AdjustmentsForCurrentTaxOfPriorPeriodUSD | 0Source | 0Source | 0Source | 0Source |
| AdjustmentsForFinanceCostsUSD | 193,000Source | 122,000Source | 93,000Source | 83,000Source |
| AdjustmentsForSharebasedPaymentsUSD | 10,926,000Source | 12,685,000Source | 3,582,000Source | 8,122,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | — | -258,000Source | 663,000Source | — |
| InterestPaidClassifiedAsFinancingActivitiesUSD | 193,000Source | 122,000Source | 93,000Source | 83,000Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 259,000Source | 10,000Source | 1,000Source | — |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 170,000Source | 444,000Source | 593,000Source | 528,000Source |
| ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivitiesUSD | 4,000Source | 58,000Source | — | — |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | — | 7,500,000Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Financial Items | ||||
| AdministrativeExpenseUSD | 17,768,000Source | 20,641,000Source | 9,947,000Source | 15,291,000Source |
| BasicEarningsLossPerShareUSD per share | -52.8Source | -2.32Source | -0.62Source | -0.23Source |
| CurrentTaxExpenseIncomeUSD | 259,000Source | 10,000Source | 1,000Source | 1,000Source |
| DeferredTaxExpenseIncomeUSD | 0Source | 0Source | 0Source | 0Source |
| DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD | 0Source | 0Source | 0Source | 0Source |
| DepreciationRightofuseAssetsUSD | 289,000Source | 587,000Source | 593,000Source | 528,000Source |
| DilutedEarningsLossPerShareUSD per share | -52.8Source | -2.32Source | -0.62Source | -0.23Source |
| EmployeeBenefitsExpenseUSD | 19,556,000Source | 23,540,000Source | 19,210,000Source | 27,742,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | 10,926,000Source | 12,685,000Source | 3,582,000Source | 8,122,000Source |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedUSD | 67,000Source | 122,000Source | 96,000Source | 56,000Source |
| FinanceCostsUSD | 179,000Source | 150,000Source | 93,000Source | 83,000Source |
| ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD | 13,000,000Source | 0Source | 0Source | 3,000,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | 259,000Source | 10,000Source | 1,000Source | 1,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 179,000Source | 150,000Source | 93,000Source | 83,000Source |
| OtherIncomeUSD | 1,489,000Source | 1,217,000Source | 1,447,000Source | 1,054,000Source |
| PostemploymentBenefitExpenseDefinedBenefitPlansUSD | 300,000Source | 499,000Source | 662,000Source | 749,000Source |
| ProfitLossBeforeTaxUSD | -53,599,000Source | -172,591,000Source | -240,810,000Source | -94,796,000Source |
| ProfitLossFromOperatingActivitiesUSD | — | — | 976,000Source | — |
| ResearchAndDevelopmentExpenseUSD | 24,566,000Source | 34,193,000Source | 35,457,000Source | 35,568,000Source |
| RevenueFromInterestUSD | 480,000Source | 753,000Source | 431,000Source | 467,000Source |